Evidence map›Paper›PMID 38386957›Full record

ArticleJCO global oncology2024

SMART-ESAS: Smartphone Monitoring and Assessment in Real Time of Edmonton Symptom Assessment System Scores for Patients With Cancer.

Chitrakshi Nagpal, Atul Sharma, Sameer Bakhshi, Prabhat Singh Malik, Hardik Gupta, Chetanya Mittal, Sneha Gund, Akash Kumar, Aparna Sharma, Deepam Pushpam and 4 more

Abstract read
In one paragraph

Article in JCO global oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Chitrakshi NagpalDepartment of Medical Oncology, Dr B.R.A. IRCH, All India Institute of Medical Sciences, New Delhi, India.ORCID 0000-0002-7352-2446
Atul SharmaDepartment of Medical Oncology, Dr B.R.A. IRCH, All India Institute of Medical Sciences, New Delhi, India.ORCID 0000-0002-0372-5336
Sameer BakhshiDepartment of Medical Oncology, Dr B.R.A. IRCH, All India Institute of Medical Sciences, New Delhi, India.ORCID 0000-0001-9367-4407
Prabhat Singh MalikDepartment of Medical Oncology, Dr B.R.A. IRCH, All India Institute of Medical Sciences, New Delhi, India.ORCID 0000-0003-0205-8559
Hardik GuptaAll India Institute of Medical Sciences, New Delhi, India.ORCID 0000-0003-3769-9938
Chetanya MittalAll India Institute of Medical Sciences, New Delhi, India.ORCID 0009-0006-7517-9625
Sneha GundDepartment of Medical Oncology, Dr B.R.A. IRCH, All India Institute of Medical Sciences, New Delhi, India.
Akash KumarDepartment of Medical Oncology, National Cancer Institute (NCI), All India Institute of Medical Sciences, Jhajjar, India.ORCID 0000-0003-3978-0879
Aparna SharmaDepartment of Medical Oncology, National Cancer Institute (NCI), All India Institute of Medical Sciences, Jhajjar, India.ORCID 0000-0002-9071-5426
Deepam PushpamDepartment of Medical Oncology, Dr B.R.A. IRCH, All India Institute of Medical Sciences, New Delhi, India.
Sachin KhuranaDepartment of Medical Oncology, Dr B.R.A. IRCH, All India Institute of Medical Sciences, New Delhi, India.ORCID 0000-0002-6308-5481
Raja PramanikDepartment of Medical Oncology, Dr B.R.A. IRCH, All India Institute of Medical Sciences, New Delhi, India.ORCID 0000-0003-0483-6254
Nishkarsh GuptaDepartment of Onco-anaesthesia and Palliative Medicine, Dr B.R.A. IRCH, All India Institute of Medical Sciences, New Delhi, India.ORCID 0000-0002-8444-2564
Atul BatraDepartment of Medical Oncology, Dr B.R.A. IRCH, All India Institute of Medical Sciences, New Delhi, India.ORCID 0000-0002-1934-8408

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeSerial patient-reported outcome (PRO) measurements in clinical practice are associated with a better quality of life and survival. Recording electronic PROs using smartphones is an efficient way to implement this. We aimed to assess the feasibility of the electronically filled Edmonton Symptom Assessment System (e-ESAS) scale in the lower-middle-income country (LMIC) setting.

methodsBaseline clinical features and conventional paper-based ESAS (p-ESAS) were collected in newly diagnosed patients with solid organ tumors. Text message link was sent to these patients for filling e-ESAS. ESAS was categorized into physical, psychological, and total symptom domains. Scores were divided into none to mild (0-3) and moderate to severe (4-10). Intraclass correlation coefficients (ICCs) were used to determine the correlation between p-ESAS and e-ESAS. Multivariable logistic regression was used to identify independent factors affecting symptom burden.

resultsOf 1,160 participants who filled out p-ESAS, 595 completed both e-ESAS and p-ESAS questionnaires and were included in the final analysis. Moderate to severe physical, psychological, and total symptom scores were seen in 39.8%, 40%, and 39% of participants. Tiredness and anxiety were the most common physical and psychological symptoms, respectively. ICCs between the p-ESAS and e-ESAS varied between 0.75 and 0.9. Total symptom scores were independently predicted by metastatic disease (odds ratio [OR], 1.83; 95% CI, 1.26 to 2.67;

conclusionPaper-based and electronically filled ESASs have good intraobserver reliability across individual symptoms and domain scores in a representative cohort at a tertiary care institute in the LMIC. This may help us incorporate e-ESAS in routine clinical care in the real-world setting with financial, infrastructural, and manpower limitations.

Indexed as

NeoplasmsQuality of LifeHumansReproducibility of ResultsSmartphoneSymptom Assessment

Identifiers

PMID38386957
PMCPMC10898676

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.